AI scans could spot deadly uterine cancer earlier
NCT ID NCT07269535
Summary
This study aims to test a new artificial intelligence (AI) tool designed to help doctors tell the difference between common, non-cancerous uterine fibroids and a rare, aggressive cancer called uterine sarcoma using MRI scans. It will involve 500 women who are already scheduled for surgery or long-term monitoring for a uterine tumor. The goal is to see if this computer model works reliably in real-world clinics to help identify high-risk patients earlier and guide their care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AI (ARTIFICIAL INTELLIGENCE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.